Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1976-2-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0078-5334
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
587-90
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:4534195-Adult,
pubmed-meshheading:4534195-Endopeptidases,
pubmed-meshheading:4534195-Eye Diseases,
pubmed-meshheading:4534195-Hemorrhage,
pubmed-meshheading:4534195-Humans,
pubmed-meshheading:4534195-Male,
pubmed-meshheading:4534195-Middle Aged,
pubmed-meshheading:4534195-Urokinase-Type Plasminogen Activator,
pubmed-meshheading:4534195-Visual Acuity,
pubmed-meshheading:4534195-Vitreous Body
|
pubmed:year |
1974
|
pubmed:articleTitle |
Intravitreal urokinase in the treatment of vitreous haemorrhage.
|
pubmed:publicationType |
Journal Article
|